(A) Cells were pretreated with or without GLP-1 (10 nM) for 1 h in the presence or absence of Ex-9 (10 nM), incubated with H 2 O 2 (1 mM) for 12 h, and then stained with primary antibodies of LC3II followed by staining with secondary antibodies
Dramatic inhibition of amiodarone metabolism induced by grapefruit juice
Another GLP-1/GIP/glucagon receptor triagonist known as retatrutide (previously LY3437943) was developed by Eli Lilly in 2022 leading to weight loss, reduced fat mass, decreased blood glucose and insulin levels in obese mice, which was attributed to increased energy expenditure and lipid oxidation [62]
Um, and then people who, um, You know, have active, pretty, intense, disordered eating
J Physiol 364:105112
Vukojevic et al